Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 13 h ago

Inspire Medical Systems, Inc.: D. E. SHAW & CO, L.P. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

D. E. Shaw & Co. amended its Schedule 13G filing for Inspire Medical Systems, disclosing a revised passive stake in the medical device maker under SEC accession 0001104659-26-128324. The filing updates the hedge fund's previously reported position in Inspire, which develops neurostimulation devices for sleep apnea. The specific size and direction of the stake change were not detailed in the headline disclosure. Investors watch 13G amendments for signals about institutional sentiment toward the company.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

D. E. Shaw & Co., L.P., Inspire Medical Systems, Inc.